Abstract:To construct the attenuated Salmonella typhimurium strain SL3261 vaccine expressing the neutrophil-activating protein of Helicobacter pylori(Hp-NAP) and to investigate its immune protection in mouse model with human H.pylori infection, the recombinant prokaryotic expression plasmid pTrc99A-NAP was constructed with molecular clone techniques, and this expression vector was identified successively by PCR, enzyme digestion analysis and sequencing. The homology was compared with the cloned Hp-NAP gene and the related genes in GenBank. Meanwhile, the vaccine strain SL3261 was transformed by pTre99A-NAP.After cultivation, the positive colonies were picked out and identified with PCR and enzyme digestion analysis again. The expression of the Hp-HAP protein in SL3621 strain of bacteria was identified by SDS-PAGE, thin layer scanning and Western blotting analysis. BALB/c mice were randomly divided into 4 groups and immunized orally with normal saline (group A),attenuated S.typhimurium SL3216 vaccine(group B), SN3216 vaccine bearing pTrc99A(group C) and SN3216 vaccine bearing pTrc99A-NAP (group D),respectively. Four weeks after the last immunization, all the mice were challenged with H.pylori (1×10~7 CFU per mouse) twice through oral route, and then were sacrificed 4 weeks after challenging with H.pylori. The gastric tissue specimens were taken for examination with modified Giemsa staining and for quantitative cultivation of bacteria, to observe the colonization of H.pylori.The experimental results showed that the homology between the cloned Hp-NAP gene and the related genes in GenBank could reach up to 98% of their nucleotide and the deduced amino acid sequences,and the expression of Hp-NAP protein could be detected in the cultural fluids of the cultivated SL3261 strain of bacteria. The relative molecular mass (Mr) of the expressed protein was about 150 000 and the quantity of expression accounted for 37.5% of the total bacterial protein.The expressed newly generated protein could react specifically with mouse polyclonal anti-serum against H.pylori. In the mouse model, it was demonstrated that the colonization density in gastric tissues in group D reduced significantly in comparison with that of group A, B and C with a statistically significant differences. It is concluded that the attenuated Salmonella typhi-murium strain SL3216 vaccine expressing HP-NAP has been established successfully and this strain of vaccine could confer certain extend of immune protection to H.pylori,thus providing to serve as the candidate for the development of multiple recombinant attenuated S.typhimurium vaccine.

Therapeutic Vaccination Against Helicobacter Pylori Infection with Recombinant Attenuated Salmonella Typhimurium Urease B Snbunit and Catalase in Mice

Therapeutic vaccination against Helicobacter pylori infection with attenuated recombinant Salmonella typhimurium urease B subunit and catalase in mice

Oral Vaccination of Mice Against Helicobacter Pylori with Recombinant Lactococcus Lactis Expressing Urease Subunit B.

THl-type Protective Immunity and Postimmunization Gastritis Induced by Attenuated Salmonella Typhimurium Expressing Helicobacter Pyiori Antigens in Mice

Immunization Against Helicobacter Pylori Infection with Multiple Recombinant Attenuated Salmonella Typhimurium Vaccines

Oral Immunization of Mice with Vaccine of Attenuated Salmonella Typhimurium Expressing Helicobacter Pylori Urease B Subunit.

[Immunoprotective Effects of Helicobacter Pylori UreB and HpaA Bivalence Recombinant Vaccine with Inner Adjuvant on Experimental Infection in Mice].

Immunization With Attenuated Salmonella Typhimurium Producing Catalase In Protection Against Gastric Helicobacter Pylori Infection In Mice

Immunoprotection of Mice Against Helicobacter Pylori Infection by Oral Immunization with Attenuated Salmonella Typhimurium Expressing Hpaa Gene of Helicobacter Pylori

Prevention of the Helicobacter Pylori Infection in Mice with Recombinant Attenuated Salmonella Typhimurium Vaccine Expressing the Neutrophil-Activating Protein

Oral Immunization with Silkworm Pupae Powder Containing Recombinant Ureb of Helicobacter Pylori Affords Prophylactic and Therapeutic Effects Against Helicobacter Pylori Infection in Mice

Immunoprotection of Recombinant Antigen LTB-UreB-HpaA in Helicobacter Pylori Infected Mice and Immunoenhancement of the Inner Adjuvant LTB

Attenuated Salmonella Typhimurium Bivalent Vaccine Strain Expressing Urease A Subunit and Catalase Induces Protective Immunity Against Helicobacter Pylori Infection

Oral multivalent epitope vaccine, based on UreB, HpaA, CAT, and LTB, for prevention and treatment of Helicobacter pylori infection in C57BL / 6 mice

Oral immunization of BALB/c mice with recombinant Helicobacter pylori antigens and double mutant heat-labile toxin (dmLT) induces prophylactic protective immunity against H. pylori infection

Prophylactic and Therapeutic Efficacy of the Epitope Vaccine CTB-UA Against Helicobacter Pylori Infection in a BALB/c Mice Model.

Protective immunity enhanced Salmonella vaccine vectors delivering Helicobacter pylori antigens reduce H. pylori stomach colonization in mice

Outer membrane vesicles from genetically engineered Salmonella enterica serovar Typhimurium presenting Helicobacter pylori antigens UreB and CagA induce protection against Helicobacter pylori infection in mice

Identification and Immunoprotective Effect of Prokaryotic Expression Product of Ltb-Hpaa Fusion Gene

Oral Immunization with Recombinant Lactococcus Lactis Delivering a Multi-Epitope Antigen CTB-UE Attenuates Helicobacter Pylori Infection in Mice.

Oral Administration of a Shigella 2aT32-Based Vaccine Expressing UreB-HspA Fusion Antigen With and Without Parenteral rUreB-HspA Boost Confers Protection Against Helicobacter pylori in Mice Model